Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens

Naoe Goto, Hisashi Tsurumi, Hideko Goto, Yoriko Ino Shimomura, Senji Kasahara, Takeshi Hara, Ichiro Yasuda, Masahito Shimizu, Nobuo Murakami, Takeshi Yoshikawa, Kenji Fukuno, Takeshi Takahashi, Yusuke Kito, Tsuyoshi Takami, Hisataka Moriwaki

Research output: Contribution to journal › Article › peer-review

51 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens'. Together they form a unique fingerprint.

Medicine & Life Sciences